JNJayne M. Ness

Jayne M. Ness

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jayne M. Ness has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis

    by Benjamin M. Greenberg, Theron Charles Casper, Soe S. Mar, Jayne M. Ness, Patricia Plumb, Shannon Liang, Manu Goyal, Bianca Weinstock-Guttman, Moses Rodriguez, Gregory S. Aaen, et al.

    Background and Objective The objective of this study was to determine whether family members of patients with pediatric multiple sclerosis (MS) have an increased prevalence of autoimmune conditions compared with controls. Methods Data collected during a pediatric MS case-control study of risk factors included information about various autoimmune diseases in family members. The frequency of these disorders was compared between cases and controls. Results There was an increased rate of autoimmune diseases among family members of pediatric MS cases compared with controls with first-degree history of MS excluded (OR = 2.27, 95% CI 1.71–3.01, p < 0.001). There was an increased rate of MS among second-degree relatives of pediatric MS cases compared with controls (OR = 3.47, 95% CI 1.36–8.86, p = 0.009). The OR for MS was 2.64 when restricted to maternal relatives and 6.37 when restricted to paternal relatives. Discussion The increased rates of autoimmune disorders, including thyroid disorders and MS among families of patients with pediatric MS, suggest shared genetic factors among families with children diagnosed with pediatric MS.


  • Open Access

    BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

    by Michael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, Anna L Travelstead, Jerry A Colliver, Jayne M Ness, Richard M Ransohoff

    B-cell dysregulation has been implicated but not fully characterized in pediatric opsoclonus-myoclonus syndrome (OMS), a neuroblastoma-associated neuroinflammatory disorder.